@reapplix.com
Diabetic foot ulcers have a debilitating impact on patients.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Reapplix is a brand that understands the personal nature of every wound and the importance of each patient in the healing process. Established in 2008, Reapplix specializes in the biological treatment and management of diabetic foot ulcers. Their innovative and evidence-based solution, the patented 3CPatch® System, is made entirely from the patient's own blood, requiring no reagents or additives.
Headquartered in Denmark, Reapplix has sales and distribution teams in the US and Europe. In fact, their groundbreaking work won them the prestigious 2018 EY Entrepreneur of the Year Award in the life science category. With the rising global prevalence of diabetes, diabetic foot ulcers have become a significant public healthcare concern due to their high costs and complications.
Reapplix aims to address this issue by offering their highly effective and cost-efficient solution. The brand's founders, Niels Erik Holm and Rasmus Lundquist, are successful entrepreneurs dedicated to providing value-based healthcare solutions. With their extensive experience and expertise, Reapplix is committed to improving the lives of patients and making a positive impact on society.
For those seeking a personalized and innovative solution for wound treatment, Reapplix and their 3CPatch® System are the perfect choice
Company Type
Privately Held
Company Size
11-50
Year Founded
2008
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online